surance coverage to the extent such State law pro-
vides greater benefits with respect to osteoporosis 
detection or prevention. 
‘‘(2) CONSTRUCTION.—Section 2723(a)(1) shall 
not be construed as superseding a State law de-
scribed in paragraph (1).’’. 
(B) Section 2723(c) of such Act (42 U.S.C. 
300gg–23(c)) is amended by striking ‘‘section 2704’’ 
and inserting ‘‘sections 2704 and 2707’’. 
(2) ERISA AMENDMENTS.—(A) Subpart B of 
part 7 of subtitle B of title I of the Employee Re-
tirement Income Security Act of 1974 is amended by 
adding at the end the following new section: 
‘‘SEC. 714. STANDARDS RELATING TO BENEFITS FOR BONE 
MASS MEASUREMENT. 
‘‘(a) REQUIREMENTS FOR COVERAGE OF BONE MASS 
MEASUREMENT.—A group health plan, and a health in-
surance issuer offering group health insurance coverage, 
shall include (consistent with this section) coverage for 
bone mass measurement for beneficiaries and participants 
who are qualified individuals. 
‘‘(b) DEFINITIONS RELATING
TO COVERAGE.—In 
this section: 
‘‘(1) BONE
MASS
MEASUREMENT.—The term 
‘bone mass measurement’ means a radiologic or
radioisotopic procedure or other procedure approved 
by the Food and Drug Administration performed on 
an individual for the purpose of identifying bone 
mass or detecting bone loss or determining bone 
quality, and includes a physician’s interpretation of 
the results of the procedure. Nothing in this para-
graph shall be construed as requiring a bone mass 
measurement to be conducted in a particular type of 
facility or to prevent such a measurement from 
being conducted through the use of mobile facilities 
that are otherwise qualified. 
‘‘(2) QUALIFIED INDIVIDUAL.—The term ‘quali-
fied individual’ means an individual who—
‘‘(A) is at clinical risk for osteoporosis, in-
cluding an estrogen-deficient woman; 
‘‘(B) has vertebral abnormalities; 
‘‘(C) is receiving chemotherapy or long-
term gluococorticoid (steroid) therapy; 
‘‘(D) has primary hyperparathyroidism, 
hyperthyroidism, or excess thyroid replacement; 
or 
‘‘(E) is being monitored to assess the re-
sponse to or efficacy of approved osteoporosis 
drug therapy.
‘‘(c) LIMITATION ON FREQUENCY REQUIRED.—The 
standards established under section 2707(c) of the Public 
Health Service Act shall apply to benefits provided under 
this section in the same manner as they apply to benefits 
provided under section 2707 of such Act. 
‘‘(d) RESTRICTIONS ON COST-SHARING.—
‘‘(1) IN GENERAL.—Subject to paragraph (2), 
nothing in this section shall be construed as pre-
venting a group health plan or issuer from imposing 
deductibles, coinsurance, or other cost-sharing in re-
lation to bone mass measurement under the plan (or 
health insurance coverage offered in connection with 
a plan). 
‘‘(2) LIMITATION.—Deductibles, coinsurance, 
and other cost-sharing or other limitations for bone 
mass measurement may not be imposed under para-
graph (1) to the extent they exceed the deductibles, 
coinsurance, and limitations that are applied to simi-
lar services under the group health plan or health 
insurance coverage. 
‘‘(e) PROHIBITIONS.—A group health plan, and a 
health insurance issuer offering group health insurance 
coverage in connection with a group health plan, may 
not—